var data={"name":"Antimicrobial drugs","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Antibiotic resistance","type":"SUBSECTION","items":[{"name":"Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=infection-due-to-coagulase-negative-staphylococci-epidemiology-microbiology-and-pathogenesis"},{"name":"Mechanisms of antibiotic resistance in enterococci","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mechanisms-of-antibiotic-resistance-in-enterococci"},{"name":"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=resistance-of-streptococcus-pneumoniae-to-beta-lactam-antibiotics"},{"name":"Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=resistance-of-streptococcus-pneumoniae-to-the-fluoroquinolones-doxycycline-and-trimethoprim-sulfamethoxazole"},{"name":"Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamides, and ketolides","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=resistance-of-streptococcus-pneumoniae-to-the-macrolides-azalides-lincosamides-and-ketolides"}]},{"name":"Antibiotics — Aminoglycosides","type":"SUBSECTION","items":[{"name":"Aminoglycosides","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=aminoglycosides"},{"name":"Dosing and administration of parenteral aminoglycosides","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=dosing-and-administration-of-parenteral-aminoglycosides"},{"name":"Manifestations of and risk factors for aminoglycoside nephrotoxicity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity"},{"name":"Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-and-prevention-of-aminoglycoside-nephrotoxicity-and-ototoxicity"}]},{"name":"Antibiotics — Beta-lactams","type":"SUBSECTION","items":[{"name":"Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=beta-lactam-antibiotics-mechanisms-of-action-and-resistance-and-adverse-effects"},{"name":"Cephalosporins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cephalosporins"},{"name":"Combination beta-lactamase inhibitors, carbapenems, and monobactams","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=combination-beta-lactamase-inhibitors-carbapenems-and-monobactams"},{"name":"Overview of carbapenemase-producing gram-negative bacilli","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-carbapenemase-producing-gram-negative-bacilli"},{"name":"Penicillin allergy: Delayed hypersensitivity reactions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=penicillin-allergy-delayed-hypersensitivity-reactions"},{"name":"Penicillin allergy: Immediate reactions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=penicillin-allergy-immediate-reactions"},{"name":"Penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=penicillin-antistaphylococcal-penicillins-and-broad-spectrum-penicillins"}]},{"name":"Antibiotics — General","type":"SUBSECTION","items":[{"name":"Antimicrobial stewardship in hospital settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimicrobial-stewardship-in-hospital-settings"},{"name":"Antimicrobial stewardship in outpatient settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimicrobial-stewardship-in-outpatient-settings"},{"name":"Extended-spectrum beta-lactamases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=extended-spectrum-beta-lactamases"},{"name":"Overview of antibacterial susceptibility testing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-antibacterial-susceptibility-testing"},{"name":"Prolonged infusions of beta-lactam antibiotics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prolonged-infusions-of-beta-lactam-antibiotics"}]},{"name":"Antibiotics — Other","type":"SUBSECTION","items":[{"name":"Azithromycin, clarithromycin, and telithromycin","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=azithromycin-clarithromycin-and-telithromycin"},{"name":"Clindamycin: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clindamycin-an-overview"},{"name":"Metronidazole: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metronidazole-an-overview"},{"name":"Pharmacology of antimicrobial agents for treatment of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-antimicrobial-agents-for-treatment-of-methicillin-resistant-staphylococcus-aureus-and-vancomycin-resistant-enterococcus"},{"name":"Polymyxins: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=polymyxins-an-overview"},{"name":"Tetracyclines","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tetracyclines"},{"name":"Trimethoprim-sulfamethoxazole: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=trimethoprim-sulfamethoxazole-an-overview"}]},{"name":"Antibiotics — Quinolones","type":"SUBSECTION","items":[{"name":"Fluoroquinolones","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=fluoroquinolones"}]},{"name":"Antibiotics — Vancomycin","type":"SUBSECTION","items":[{"name":"Vancomycin hypersensitivity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vancomycin-hypersensitivity"},{"name":"Vancomycin: Parenteral dosing, monitoring, and adverse effects in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vancomycin-parenteral-dosing-monitoring-and-adverse-effects-in-adults"}]},{"name":"Antifungals","type":"SUBSECTION","items":[{"name":"Antifungal susceptibility testing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antifungal-susceptibility-testing"},{"name":"Pharmacology of amphotericin B","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-amphotericin-b"},{"name":"Pharmacology of azoles","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-azoles"},{"name":"Pharmacology of echinocandins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-echinocandins"},{"name":"Pharmacology of flucytosine (5-FC)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-flucytosine-5-fc"}]},{"name":"Antiparasitic drugs","type":"SUBSECTION","items":[{"name":"Anthelminthic therapies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=anthelminthic-therapies"},{"name":"Antimalarial drugs: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimalarial-drugs-an-overview"},{"name":"Antiprotozoal therapies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiprotozoal-therapies"}]},{"name":"Antitubercular drugs","type":"SUBSECTION","items":[{"name":"Ethambutol: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ethambutol-an-overview"},{"name":"Isoniazid hepatotoxicity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=isoniazid-hepatotoxicity"},{"name":"Isoniazid: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=isoniazid-an-overview"},{"name":"Pyrazinamide: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pyrazinamide-an-overview"},{"name":"Rifamycins (rifampin, rifabutin, rifapentine)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rifamycins-rifampin-rifabutin-rifapentine"}]},{"name":"Antivirals (excluding drugs for HIV)","type":"SUBSECTION","items":[{"name":"Acyclovir: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acyclovir-an-overview"},{"name":"Cidofovir: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cidofovir-an-overview"},{"name":"Famciclovir: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=famciclovir-an-overview"},{"name":"Foscarnet: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=foscarnet-an-overview"},{"name":"Ganciclovir and valganciclovir: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ganciclovir-and-valganciclovir-an-overview"},{"name":"Pharmacology of antiviral drugs for influenza","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-antiviral-drugs-for-influenza"},{"name":"Valacyclovir: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=valacyclovir-an-overview"}]}]}